US Stock MarketDetailed Quotes

AEMD Aethlon Medical

Watchlist
  • 0.5800
  • +0.1466+33.83%
Close Dec 20 16:00 ET
  • 0.5800
  • 0.00000.00%
Post 20:01 ET
8.10MMarket Cap-0.21P/E (TTM)

Aethlon Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
-21.87%-2.38M
6.05%-2.7M
9.03%-2.48M
-7.56%-10.51M
4.92%-2.95M
28.22%-1.95M
Net income from continuing operations
7.50%-2.81M
21.65%-2.57M
-1.48%-12.21M
1.68%-2.43M
-21.72%-3.47M
20.34%-3.03M
-12.94%-3.28M
-15.44%-12.03M
34.84%-2.47M
-12.65%-2.85M
Operating gains losses
----
----
-85.13%21.14K
--17.86K
----
----
----
--142.12K
--0
--0
Depreciation and amortization
-6.13%85.83K
-4.72%86.06K
49.05%359.06K
7.91%85.83K
17.08%91.47K
73.90%91.43K
194.70%90.33K
94.76%240.89K
214.12%79.54K
342.06%78.13K
Other non cash items
20,348.54%140.28K
-198.30%-1.22K
-99.41%143
-218.77%-1.22K
-104.12%-566
-62.58%686
-84.13%1.24K
-20.06%24.41K
-95.09%1.02K
15.59%13.75K
Change In working capital
1,431.75%252.82K
30.91%599.73K
632.58%478.66K
53.50%-381.63K
-22.31%421.15K
-104.51%-18.98K
697.10%458.12K
126.02%65.34K
-299.14%-820.66K
228.83%542.08K
-Change in receivables
----
----
--0
--0
----
----
----
505.98%127.97K
--0
--114.85K
-Change in prepaid assets
112.84%202.2K
-38.62%89.87K
-102.57%-10.23K
-355.34%-292.42K
-62.86%40.78K
27.49%95K
47.39%146.41K
162.54%398.17K
141.97%114.52K
123.74%109.79K
-Change in payables and accrued expense
144.41%50.62K
63.57%509.86K
520.56%488.89K
75.29%-89.2K
19.82%380.37K
-149.29%-113.99K
202.53%311.71K
-186.26%-116.25K
-163.75%-360.94K
534.55%317.44K
-Change in other working capital
----
----
----
----
----
----
----
-250.00%-344.55K
-600.00%-574.25K
--0
Cash from discontinued investing activities
Operating cash flow
18.11%-2.21M
29.60%-1.75M
3.57%-10.13M
12.94%-2.57M
-21.87%-2.38M
6.05%-2.7M
9.03%-2.48M
-7.56%-10.51M
4.92%-2.95M
28.22%-1.95M
Investing cash flow
Cash flow from continuing investing activities
0
0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
99.08%-6.77K
-459.60%-230.38K
-170.08%-943.11K
94.68%-11.29K
-161.48%-151.49K
Net PPE purchase and sale
--0
--0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
99.08%-6.77K
-459.60%-230.38K
-170.08%-943.11K
94.68%-11.29K
-161.48%-151.49K
Cash from discontinued investing activities
Investing cash flow
--0
--0
73.40%-250.87K
56.53%-4.91K
94.19%-8.81K
99.08%-6.77K
-459.60%-230.38K
-170.08%-943.11K
94.68%-11.29K
-161.48%-151.49K
Financing cash flow
Cash flow from continuing financing activities
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
9,501.75%177.13K
-100.12%-9.84K
73.99%1.08M
-48.67%8.91M
75.23%-2.64K
86.10%-1.88K
Net common stock issuance
--0
395.74%5.38M
-85.19%1.32M
--49.76K
--186.5K
--0
75.34%1.09M
-48.86%8.93M
--0
--0
Net other financing activities
61.07%-3.83K
39.35%-5.08K
-178.38%-34.78K
-172.76%-7.19K
-397.51%-9.37K
---9.84K
---8.37K
85.82%-12.49K
75.23%-2.64K
86.10%-1.88K
Cash from discontinued financing activities
Financing cash flow
61.07%-3.83K
399.12%5.38M
-85.56%1.29M
1,715.02%42.57K
9,501.75%177.13K
-100.12%-9.84K
73.99%1.08M
-48.67%8.91M
75.23%-2.64K
86.10%-1.88K
Net cash flow
Beginning cash position
-29.46%9.16M
-62.18%5.53M
-14.80%14.62M
-54.17%8.06M
-47.88%10.26M
-13.49%12.99M
-14.80%14.62M
73.19%17.16M
-14.13%17.59M
-15.38%19.69M
Current changes in cash
18.46%-2.22M
322.12%3.63M
-258.91%-9.09M
14.62%-2.53M
-4.99%-2.21M
-158.11%-2.72M
23.98%-1.64M
-134.94%-2.53M
10.88%-2.96M
24.56%-2.1M
Effect of exchange rate changes
581.99%5.09K
-593.55%-1.29K
135.37%2.11K
62.11%-2.26K
--5.61K
---1.06K
---186
---5.96K
---5.96K
--0
End cash Position
-32.32%6.95M
-29.46%9.16M
-62.18%5.53M
-62.18%5.53M
-54.17%8.06M
-47.88%10.26M
-13.49%12.99M
-14.80%14.62M
-14.80%14.62M
-14.13%17.59M
Free cash flow
18.31%-2.21M
35.58%-1.75M
9.33%-10.38M
13.11%-2.57M
-13.51%-2.39M
25.06%-2.71M
2.07%-2.71M
-13.17%-11.45M
10.67%-2.96M
24.26%-2.1M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M-21.87%-2.38M6.05%-2.7M9.03%-2.48M-7.56%-10.51M4.92%-2.95M28.22%-1.95M
Net income from continuing operations 7.50%-2.81M21.65%-2.57M-1.48%-12.21M1.68%-2.43M-21.72%-3.47M20.34%-3.03M-12.94%-3.28M-15.44%-12.03M34.84%-2.47M-12.65%-2.85M
Operating gains losses ---------85.13%21.14K--17.86K--------------142.12K--0--0
Depreciation and amortization -6.13%85.83K-4.72%86.06K49.05%359.06K7.91%85.83K17.08%91.47K73.90%91.43K194.70%90.33K94.76%240.89K214.12%79.54K342.06%78.13K
Other non cash items 20,348.54%140.28K-198.30%-1.22K-99.41%143-218.77%-1.22K-104.12%-566-62.58%686-84.13%1.24K-20.06%24.41K-95.09%1.02K15.59%13.75K
Change In working capital 1,431.75%252.82K30.91%599.73K632.58%478.66K53.50%-381.63K-22.31%421.15K-104.51%-18.98K697.10%458.12K126.02%65.34K-299.14%-820.66K228.83%542.08K
-Change in receivables ----------0--0------------505.98%127.97K--0--114.85K
-Change in prepaid assets 112.84%202.2K-38.62%89.87K-102.57%-10.23K-355.34%-292.42K-62.86%40.78K27.49%95K47.39%146.41K162.54%398.17K141.97%114.52K123.74%109.79K
-Change in payables and accrued expense 144.41%50.62K63.57%509.86K520.56%488.89K75.29%-89.2K19.82%380.37K-149.29%-113.99K202.53%311.71K-186.26%-116.25K-163.75%-360.94K534.55%317.44K
-Change in other working capital -----------------------------250.00%-344.55K-600.00%-574.25K--0
Cash from discontinued investing activities
Operating cash flow 18.11%-2.21M29.60%-1.75M3.57%-10.13M12.94%-2.57M-21.87%-2.38M6.05%-2.7M9.03%-2.48M-7.56%-10.51M4.92%-2.95M28.22%-1.95M
Investing cash flow
Cash flow from continuing investing activities 0073.40%-250.87K56.53%-4.91K94.19%-8.81K99.08%-6.77K-459.60%-230.38K-170.08%-943.11K94.68%-11.29K-161.48%-151.49K
Net PPE purchase and sale --0--073.40%-250.87K56.53%-4.91K94.19%-8.81K99.08%-6.77K-459.60%-230.38K-170.08%-943.11K94.68%-11.29K-161.48%-151.49K
Cash from discontinued investing activities
Investing cash flow --0--073.40%-250.87K56.53%-4.91K94.19%-8.81K99.08%-6.77K-459.60%-230.38K-170.08%-943.11K94.68%-11.29K-161.48%-151.49K
Financing cash flow
Cash flow from continuing financing activities 61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K9,501.75%177.13K-100.12%-9.84K73.99%1.08M-48.67%8.91M75.23%-2.64K86.10%-1.88K
Net common stock issuance --0395.74%5.38M-85.19%1.32M--49.76K--186.5K--075.34%1.09M-48.86%8.93M--0--0
Net other financing activities 61.07%-3.83K39.35%-5.08K-178.38%-34.78K-172.76%-7.19K-397.51%-9.37K---9.84K---8.37K85.82%-12.49K75.23%-2.64K86.10%-1.88K
Cash from discontinued financing activities
Financing cash flow 61.07%-3.83K399.12%5.38M-85.56%1.29M1,715.02%42.57K9,501.75%177.13K-100.12%-9.84K73.99%1.08M-48.67%8.91M75.23%-2.64K86.10%-1.88K
Net cash flow
Beginning cash position -29.46%9.16M-62.18%5.53M-14.80%14.62M-54.17%8.06M-47.88%10.26M-13.49%12.99M-14.80%14.62M73.19%17.16M-14.13%17.59M-15.38%19.69M
Current changes in cash 18.46%-2.22M322.12%3.63M-258.91%-9.09M14.62%-2.53M-4.99%-2.21M-158.11%-2.72M23.98%-1.64M-134.94%-2.53M10.88%-2.96M24.56%-2.1M
Effect of exchange rate changes 581.99%5.09K-593.55%-1.29K135.37%2.11K62.11%-2.26K--5.61K---1.06K---186---5.96K---5.96K--0
End cash Position -32.32%6.95M-29.46%9.16M-62.18%5.53M-62.18%5.53M-54.17%8.06M-47.88%10.26M-13.49%12.99M-14.80%14.62M-14.80%14.62M-14.13%17.59M
Free cash flow 18.31%-2.21M35.58%-1.75M9.33%-10.38M13.11%-2.57M-13.51%-2.39M25.06%-2.71M2.07%-2.71M-13.17%-11.45M10.67%-2.96M24.26%-2.1M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List

Investment Theme Top Gainers Yesterday
Top Gainers Yesterday
Intraday-0.12%